Pharmacovigilance 101: What is it and why is it important?

February 23rd, 2012

Presented by Dr. Richard Dolinar, MD

  • What is pharmacovigilance
  • Track & Trace systems for biologic medicines
  • Coding, Naming, Labeling
  • Down the Road: Interchangeability and Drug Substitution

Biosimilars 101: What are biosimilars and why should you care?

December 1st, 2011

Presented by Dr. Richard Dolinar, MD

  • What are biosimilars
  • Why are biosimilars not generics
  • Manufacturing
  • The FDA’s “biosimilar pathway”
  • Policy Considerations

Biologics 101: What are biologics and why should you care?

November 17th, 2011

Presented by Alliance Chairman, Dr. Richard Dolinar, MD

  • Role of biotechnology in medical advancements
  • What are biologics
  • Examples of biologic medicines
  • Manufacturing process
  • Chemical drugs vs. biologic medicines
  • Implications of size, variability, complexity
  • What’s next for biotechnology